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        The most important characteristics of PTSD, as an anxiety disorder, are memory disorders and 
hippocampus is one of the essential structures which plays a critical role in PTSD memory disorders. 
Traumatic events cause apoptosis and alter the expression of neurotrophic factors in hippocampus. The 
aim of this study is to evaluate the effects of β-Estradiol on behavioral responses in PTSD and to study 
its biochemical and histological mechanisms. 
We used single prolonged stress (SPS) to develop PTSD in rats. The day after, the rats received electrical 
foot shock within shock chamber. One week later, in order to test the conditioned fear responses, the 
freezing behavior of rats were examined for 5 continuous days, as they were placed back in the chamber 
without any shock. Animals received multiple injections of β-estradiol or sesame oil, immediately after 
shock and also on a daily basis through the seven days prior to the test. Hippocampal cell count was 
implemented after cresyl violet staining. We measured BDNF protein levels by ELISA kit. 
Main findings of this study confirmed that exaggerated fear response is observed in PTSD group as 
compared with control group and β-estradiol administration reduced these exaggerated behavioral 
responses. We found out that SPS decreases the density of cells in hippocampus and this effect is partly 
corrected by β-estradiol; β-estradiol increased BDNF protein level in hippocampus as compared with 
PTSD group; BDNF protein level was negatively correlated with freezing response in both SPS+β-
estradiol and SPS+sesame group. 
The results of this study is consistent with the hypothesis that decreased expression of BDNF contributes 
to memory impairment in PTSD and up regulation of BDNF by β-estradiol plays a role in memory 
treatment. 
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INTRODUCTION 
     Post-traumatic stress disorder (PTSD) is a 
stress-related mental disorder caused by 
exposure to severe traumatic events, such as war 
or natural disasters, and characterized by re-
experiencing symptoms as intrusive memories 
(flashback), hyper-arousal, and avoidance 
symptoms. Biological alterations in this disorder 
include adrenergic hyper-responsiveness [1], 
increased thyroid activity, low cortisol levels, 
and increased negative feedback sensitivity of 
the hypothalamic-pituitary-adrenal (HPA) axis 
[2]. Three brain regions are involved in the 
pathophysiology of PTSD: Amygdala, Medial 
Prefrontal Cortex, and Hippocampus. Most 
importantly, Hippocampus appears to interact 
with Amygdala during the encoding of 
emotional memories, a process which is highly 
relevant to the study of trauma and PTSD [3]. 
One neurocircuitry model of PTSD posits that 
Amygdala is hyper-responsive, medial 
prefrontal cortex is hypo-responsive, and medial 
prefrontal cortex and Hippocampus fail to 
inhibit Amygdala. Furthermore, hippocampal 
volumes have been inversely associated with 
verbal memory deficits, combat exposure 
severity, dissociative symptom severity, 
depression severity and PTSD symptom 
severity [4]. 
The rat model involving single-prolonged stress 
(SPS) is a common animal model for PTSD 
research [5]. This paradigm is thought to be a 
good model for PTSD because fear conditioning 
resembles the occurrence of a traumatic event 
 




and fear extinction forms the basis of exposure 
therapy, which is a commonly used treatment 
for anxiety [7]. Fear extinction is the process of 
replacing a fearful response to a stimulus with a 
non-fearful response. Impairment of fear 
extinction or reconsolidation plays an important 
role in the development of clinical symptoms, 
such as re-experiencing of trauma, in PTSD [11, 
13]. Hippocampus is the brain region in which 
estrogen synthesis as well as the expression of 
estrogen receptors is taking place. Estradiol 
induces formation and breakdown of new 
dendritic spines and excitatory synapses in the 
dorsal hippocampus of adult female animals [5]. 
Estrogens also influence neuroplasticity in 
Hippocampus. As for adult females, 17β-
estradiol influences apical spine density inCA1 
region of Hippocampus [7] and alters 
neurogenesis in Hippocampus [9]. Adult 
hippocampal neurogenesisis modulated by 
many factors including hippocampus-dependent 
learning and gonadal hormones, such as 
estradiol [9]. 
In recent years, it has become increasingly clear 
that estradiolal so plays important non-
reproductive roles in the brain, such as enhancing 
synaptic plasticity and exerting neurotrophic and 
neuroprotective actions [10].Estrogens have been 
established as potent neuroprotective and 
neurotrophic factors [11]. Specifically, clinical 
studies have demonstrated that estrogens enhance 
mood and cognition and delay cognitive decline 
[12]. 
Furthermore, many studies suggest that estrogens 
are able to protect against neurodegenerative 
diseases, such as Alzheimer‟s disease [13]. 
Women are twice as likely to develop PTSD as 
men, which may be related to psychosocial 
factors (gender differences in types of trauma 
exposure) or biological factors (differences in 
gonadal hormone influences). Some evidences 
point to the protective role of estrogen in 
anxiety regulation [14]. Several studies have 
found that women are more likely to report 
symptoms of depression and anxiety during 
premenstrual, postpartum, and perimenopausal 
periods when estrogen levels are low. Studies 
using rodent models of anxiety have shown that 
females in the proestrus phase of their cycle 
(marked by high estrogen levels) show less fear 
and anxiety related behaviors than females in 
the metestrus or diestrus phases (lower estrogen 
levels). Changes in endogenous levels of E2can 
alter anxiety and depressive behavior of rodents 
[14]. 
PTSD women with low estradiol exhibited 
significantly elevated conditioned responses 
during extinction training in comparison to 
control groups and they had greater symptom 
severity in comparison to those with high 
estradiol [15]. Infusions of estradiol into 
Hippocampus facilitate extinction of 
contextually conditioned fear in ovariectomized 
rats and also that estradiol may facilitate 
consolidation of extinction learning. Increased 
estradiol levels in women are associated with 
increased activations of the neural circuitry 
associated with fear extinction (ventromedial 
prefrontal cortex, hippocampus, and amygdala) 
during extinction retention [16]. 
Brain-derived neurotrophic factor (BDNF) is a 
member of the neutrophin family, and plays a 
role in neuronal birth, maturation, 
differentiation, migration and survival. It is 
necessary for dendritic growth, synaptic 
plasticity and long-term potentiation. 
Inactivation of BDNF in Hippocampus impairs 
consolidation of fear extinction in a cued fear 
conditioning paradigm [17]. Structural 
neuroimaging studies showed that hippocampal 
volumes were relatively low in PTSD patients. 
Several evidences have demonstrated a strong 
relationship between atrophy of Hippocampus 
and PTSD. Apoptosis is a genetically controlled 
and complex process, central to the development, 
homeostasis and disease, turned on in response to 
environmental signals or triggered by intrinsic 
factors, and designed to kill errant cells in an 
orderly and clean way [18]. 
 One of the hippocampal dependent behaviors 
that increases in PTSD patients is Conditioned 
Fear Response. Accordingly, this study is an 
attempt to examine this response after SPS 
procedure and then to evaluate the effects of 
administration of subcutaneous β-estradiol 
(multiple injections) in order to prevent the 
hippocampal dependent response .It was 
possible that β-estradiol would do this by 
decreasing hippocampal cell death or by 
affecting the most important factors which 
interfere with memory, such as BDNF. The 
present study investigates the neuroprotective 
effect of 17β-estradiol against SPS-induced 
hippocampal changes, using behavioral studies 
as well as biochemical and histological analyses 
in order to achieve a conclusion. 
 
 




MATERIALS AND METHODS 
 Animals 
     A total of 80 wistar rats (200–250 g) were 
housed into a cage, maintained on a 12-h 
light/dark cycle (light on from 08:00 to 20:00), 
and fed and watered ad libitum. The rats were 
obtained from the breeding colony of University 
of Damghan, Iran. All procedures were conducted 
in agreement with the National Institutes of 
Health‟s guide for care and use of laboratory 
animals. Every effort was made to minimize the 
number of animals being used per group and to 
minimize the suffering of the animals throughout 
all experimental procedures. 
Experimental groups 
    Rats were randomly assigned to two SPS and 
Shock groups(10 animals in each group).   
SPS group: the rats were treated through the 
procedures described as Single prolonged stress 
procedure.  
Shock group: the rats received a shock 
conducted through the procedure described in 
Section shock application and test of 
conditioned fear response. Then, the exposed 
animals received multiple injections of vehicle 
or β-estradiol (45 µg/kg). The first injection was 
implemented immediately after the shock and 






Single prolonged stress procedure 
     Detailed SPS procedure, as an animal model of 
PTSD, has been described in previous studies [5]. 
Briefly, the rats were restrained for 2 h and 
immediately after were forced to swim for 20 min 
in 24 
0
C water contained in a clear acrylic cylinder 
(24 cm in diameter and 50 cm in height). After 15 
min of recuperation, the animals were exposed to 
diethyl ether until they lost consciousness (for1–2 
min).  
Shock application and test of conditioned fear 
response 
Apparatus 
      An automated rodent fear conditioning system 
(TSE, Bad Homburg, Germany) was used to study 
contextual fear conditioning of each rat. 
Contextual fear conditioning took place in a 
conditioning box. The walls and the ceiling of the 
box were made of clear Plexiglass. The box was in 
an isolation cubicle (45 cm × 45 cm × 47 cm) 
containing a loud speaker and a light bulb which 
provided dim illumination. The floor of the box 
was made of 28 stainless steel rods (6 mm in 
diameter, 12 mm apart) through which foot shock 
could be accomplished by a constant current 
source. The chamber was illuminated by a single 
house light, and was cleaned before and after 
utilization. A software program was used to 
control the test in the box, and to collect, display 
and store all experimental data for „„off-line‟‟ 
analysis. One day after SPS, the stressed rats 
received electrical foot shock within the shock 
chamber, after 180s they received 4s, 1 mA shock, 
administered via the metal grid. The stressed rats 
were held in the shock chamber for another 60 s 
before being returned to the home cages.  
 




In order to test the conditioned fear response 
(CFR), a week after shock application, over 5 
continuous days the rats were placed back in the 
chamber for 5 min periods without further shock 
application. The duration of freezing (Absence of 
all visible movement expect respiration) was 
evaluated.  
Iwamoto et al. (2007) demonstrated that 24 h after 
contextual fear conditioning (FC),SPS rats 
exhibited a significant increase in contextual 
freezing as compared with sham rats [19]. 
Histological Methods 
     After the final behavior test the rats were 
anesthetized intrapertoneally with a mixture of 
ketamine (100 mg/kg) and xylazine (4 mg/kg) and 
perfused intracardially with 0.1 M phosphate 
buffer for 10 minutes followed by phosphate-
buffered 4% paraformaldehyde for 15 minutes. 
Infiltration and embedding 
    The brains were removed and Hippocampus 
was dehydrated through a graded series of 
alcohols (50%, 60%, 70%, 80%, 90%for 1 hour 
each, and 100% twice for 1.5 hours) prior to 
infiltration. After dehydration, clearing (xylene for 
twice 1.5 hour) and impregnation, the 
hippocampal blocks were embedded in disposable 
tissue molds[20]. 
Staining 
    Three animals of each group and 9 coronal 
sections (5 μm) per animal were cut at the level of 
the dorsal hippocampus and stained by cresyl 
violet. The staining solution contained 0.5g cresyl 
violet dissolved in100ml distilled water. The 
mounted sections were placed in the staining 
solution for 20-30 minutes at room temperature, 
differentiated in 0.25% acetic acid until most of 
the stain had been removed (4-8seconds) and then 
were briefly passed through absolute alcohol into 
xylene and checked microscopically. The 
differentiation was repeated in case of a necessity. 
Sections were then cleared with xylene and the 
coverslip was bonded with Entellan. The number 
of pyramidal cells in2mm
2
segments of each 
hippocampal CA1 and CA3 fields and 800-
μm
2
segments of granule cells in the dentate gyrus 
were counted in a light microscope at × 400 
magnification [20]. 
Definitions of hippocampal cell layers 
    The principal neurons in the different 
subdivisions of Hippocampus were clearly 
differentiated from each other. Neurons were 
counted based on identification of a clear and 
distinct nuclear membrane. The cell bodies of 
CA3 are large, elongated and tightly packed in a 
four to five cells deep layer. The cell bodies and 
nuclei of the pyramidal cells of CA1 are smaller 
than those of CA3.The granular layer of the DG 
contains the smallest and most densely packed cell 
bodies in Hippocampus. The cell bodies are 
packed 8-15 cells deep and have well defined 
borders[20]. 
Measurement of BDNF protein levels by 
enzyme-linked immune sorbent assay (ELISA) 
     To examine the protein levels of BDNF, we 
measured BDNF protein levels by ELISA. Two 
hour after fear conditioning tests one (day 9) and 
five (day 13), the rats were sacrificed by 
decapitation. ELISA was performed using the 
BDNF Emax Immuno Assay System kit 
(Promega, Madison, Wis., USA) according to the 
manufacturer‟s instructions[21].Briefly, 96-well 
ELISA plates (Iwaki, Chiba, Japan) were coated 
with monoclonal antibody and incubated 
overnight at 4 °C. The plates containing sample 
and blocking buffers were incubated together at 
room temperature for 1 hour, followed by 
incubation of the immobilized monoclonal 
antibody to BDNF, according to the standards. 
Duplicate samples were maintained at room 
temperature, being shaken for 2 hours. The plates 
were incubated with polyclonal antibody for 2 
hours at room temperature, and then washed, and 
incubated at room temperature with a secondary 
anti-IgY antibody conjugated to horseradish 
peroxidase for 1 hour. The plates were incubated 
in peroxidase substrate and tetramethylbenzidine 
solution to produce color reaction. The reaction 
was stopped with 1 M hydrochloric acid and the 
absorbance at 450 nm was measured with an 
automated microplate reader (SH-1000, Corona, 
Ibaraki, Japan). Standard curves were plotted for 
each plate. Values were corrected for the total 
amount of protein in the sample. The BDNF assay 
sensitivity ranged from 7.8 to 500pg/ml, 
respectively, according to the standards provided 
by Promega. Values of sections were above 
16pg/ml for each plate. 
Drug treatment 
    β-estradiol was purchased from Sigma (USA). 
β-estradiol was prepared in sesame oil (vehicle, 
Sigma-USA), and was injected in 2 ml/kg volume 
(S.C., 45mg/kg). Control animals were given 
vehicle only. The drug dose were mainly derived 
from our previous studies and a survey of reports 
on these drugs [22]. 
Statistical analysis 
    Data are presented as mean ± SEM. Data were 
analyzed by 1- and 2-way ANOVA for repeated 
 




measurements by means of SPSS 16.0. Tukey 
post hoc test was performed to determine the 
source of the detected significant differences. 
Values of P < 0.05 were considered significant. 
Relationships between behavior and BDNF 





    The aim of this experiment was to investigate 
the conditioned fear response in rats after post-
traumatic stress disorder induction by SPS. The 
rats were randomly divided into three groups: 
Shock+Sesame oil, SPS+Sesame oil and SPS+β-
estradiol(45 mg/kg) as described in section 2.2. 
Conditioned fear responses of all rats were tested 
in five following days, according to the 
procedures described in section 2.4, (Test 1-5). 
  Two-way ANOVA with repeated measurements 
on freezing data showed a significant effect of 
groups (F2, 35=20.401, P=0.000), days (F4, 
140=4.405, P=0.002), and no significant effect of 
interaction between groups and days (F8, 140 
=0.308, P=0.962). Post-hoc comparisons indicated 
that SPS+Sesame group showed significant 
increase in CFR as compared with Shock+Sesame 
group in all tests (P=0.00). Animals in this group 
were likely to “freeze” for a longer time during the 
entire period of observation as compared with 
shock group, and this result remained the same in 
five Tests. Post-hoc comparison indicated that 
there is a significant difference between 
SPS+Sesame oil and SPS+β-estradiol group (45 
mg/kg) and also that the result remained the same 
in five Tests. Rats given β-estradiol showed 
decreased percentage of freezing as compared 
with SPS group which received sesame (Figure 1). 
Comparison of conditioned fear responses 
between tests 1 and 5, in each group, with paired 
T-test showed that there was significant decrease 
in freezing in shock group and also SPS+β 
estradiol group, but the response remained 
constant in SPS+sesame oil group (Figure 2).  
Histological results 
    The animals were trained as described in 
experiment 1 and Hippocampus was stained with 
crysil violet as described in section 2.5. The 
principal neurons in the different subdivisions of 
Hippocampus were clearly differentiated from 
each other. Neurons were counted based on 
identification of a clear and distinct nuclear 
membrane. 
Number of CA1 pyramidal cells 
    One-way ANOVA showed a significant effect 
of groups (F2, 23=9.275, P=0.001). Post-hoc 
comparisons indicated that the number of CA1 
pyramidal cells in SPS+β-estradiol group was 
significantly more than SPS+sesame oil group 
(P=0.045) and SPS+sesame oil group showed 
significant decrease in the number of cells as 
compared with Shock+Sesame group (P=0.001). 
The average number of neurons in all sections of 
each group is shown in table 1 (Figure 3). 
CA3 pyramidal cells 
    One-way ANOVA showed a significant effect 
of groups (F2, 23=9.275, P=0.001). Post-hoc 
comparisons indicated that the number of CA3 
pyramidal cells in SPS+β-estradiol group was 
significantly more than SPS+sesame oil group 
(P=0.02) and SPS+sesame oil group showed 
significant decrease in the number of cells as 
compared with Shock+Sesame group (P=0.001).  
The average number of neurons in all sections of 
each of group is shown in table 1(Figure 3). 
DG granule cells  
    The total number of DG neurons was 
significantly different among groups (F2, 
21=2.826, P=0.082). There was no significant 
difference in the number of cells between 
SPS+sesame oil and SPS+β-estradiol groups. 
SPS+sesame oil group showed significant 
decrease in the number of cells as compared with 
Shock+Sesame group (P=0.001). The average 
number of DG neurons is shown in table 1(Figure 
3). 
Biochemical results: measurement of BDNF 
protein levels 
  We measured total protein in right and left 
hippocampus, BDNF protein levels and the ratio 
of these two in SPS+sesame oil and SPS+β-
estradiol groups by ELISA. These measurements 
were done after the first (day 9) and fifth (day 
13)tests.   
T-test showed a significant difference between the 
SPS+sesame oil and SPS+β-estradiol groups9 
days after SPS induction(p < 0.01). But this 
difference was not found to be statistically 





























Figure 1. Conditioned fear response which was measured as percentage of time spent freezing during tests. Experimental 
groups were described in section 2.2. And rats were tested in five following weeks, according to the procedures described in 
section 2.4. 
** P< 0.01 as compared with Shock group; # P< 0.05 as compared with SPS+Sesame oil group; ## P< 0.01 as compared with 

























Figure 2. Comparison of conditioned fear responses between tests 1 and 5, in each group. 













































Figure 3. The number of principal cells in different regions of Hippocampus.Cell count was done according to the procedures 
described in section 2.5.2.* P< 0.05 as compared with SPS+Sesame oil group; # P< 0.05 as compared withShock group. Data 


























Figure 4. BDNF protein levelsin right and left hippocampusby ELISA.Measurements were done after the first and fifth tests. * 





























































Figure 5. Correlations between behavior and BDNF protein levels. Up:in SPS+sesame group; down: in SPS+β-estradiolgroup. 
BDNF protein level wasnegatively correlated with freezing responseeither in SPS+β-estradiol (r = -0.87,p = 0.02) or 
SPS+Sesame group (r = -0.82; p = -0.04). 
 
Correlations between behavior and BDNF 
protein levels 
As we showed in the previous session, there was a 
significant increase in BDNF protein level in 
SPS+β-estradiol group as compared with 
SPS+sesame group after the first test. We also 
reported that the freezing response in SPS+β-
estradiol group is significantly lower than 
SPS+sesame group. In order to examine the 
correlation between these two factors, we two-
tailed Pearson correlations. BDNF protein level 
was negatively correlated with freezing response 
either in SPS+β-estradiol (Pearson correlation 
coefficient, two-tailed, r=-0.87,p= 0.02) or in 
SPS+sesame group (Pearson correlation 




   The main findings in the present study were: (1) 
SPS rats exhibited enhancement of contextual fear 
in comparison to Shock rats, and this effect was 
permanent in five fear tests. Rats given β-estradiol 
(45 mg/kg) showed decreased percent of freezing 
as compared with SPS group that received sesame 
(2) SPS procedure reduced the number of CA3 and 
CA1 pyramidal cells, and β-estradiol treatment 
elevated the number of cells. (3) BDNF protein in 
 




SPS+ β-estradiol rats was significantly higher than 
that in SPS+sesame oil rats. (4)BDNF protein 
level was negatively correlated with freezing 
response in both SPS+β-estradiol and 
SPS+sesame group. 
β-estradiol and conditioned fear response 
     In the present study, we examined the effects of 
SPS model for PTSD-like symptoms. One day 
after SPS, the rats were placed in a conditioning 
chamber with a grid floor. During a conditioning 
session, the rats were exposed to foot shock. One 
week after conditioning, the animals were placed 
again in the same chamber and freezing was 
examined. The maintenance of the response was 
measured for five following days. Findings 
indicated that after one week conditioned fear 
response was enhanced in the SPS rats. This 
finding confirms the results of other studies 
showing that SPS model enhances fear 
conditioning response after one week [5]. The 
freezing time in shock group was around 30% of 
the initial time and this was half of that in 
SPS+Sesame oil group.  
Comparison of conditioned fear responses 
between tests 1 and 5 in each group showed that 
there was a significant decrease in the freezing 
time in shock group, but this response remained 
constant in SPS+sesame oil group. It means that 
the enhancement of fear response in this model of 
PTSD induction lasted even after several tests, as 
previous studies have shown [23]. 
Extinction is a process whereby a learned fear 
response is reduced via repeated presentation of 
the conditioned stimulus. Patients suffering from 
PTSD are impaired in extinction of learned fear 
[24].  
Research in basic science and functional 
neuroimaging has helped to identify three brain 
regions that may be involved in the 
pathophysiology of PTSD: Amygdala, Medial 
Prefrontal Cortex, and Hippocampus. Numerous 
molecular and clinical studies have implicated 
estrogen in modulating brain function including 
that related to mood [25]. 
The brain is widely responsive to gonadal 
hormones. Not only is the hypothalamus regulated 
by these hormones in relation to reproductive 
behavior and neuroendocrine physiology, but also 
structures like Hippocampus and midbrain 
serotonin system undergo sexual differentiation. 
Estrogens regulate dorsal hippocampus during the 
estrous cycle of the female rat, and the functional 
consequences include changes in 
neurotransmission and memory. This finding was 
surprising because, until recently, Hippocampus 
was known as a brain region in which cells‟ 
nuclear estrogen receptors are present in scattered 
inhibitory interneurons but not in principal 
neurons where spine formation occurs. Yet the 
effects of ovarian hormones on synaptic turnover 
were as impressive in Hippocampus as those in 
the ventromedial hypothalamus, a classic estrogen 
target area of the brain for female sexual behavior 
[26]. 
Female rats undergoing extinction learning during 
the proestrous phase of the estrus cycle (when 
estradiol and progesterone levels are elevated) 
exhibited better extinction memory during 
subsequent extinction recall (i.e. retention) testing. 
Moreover, exogenously administered estradiol and 
progesterone facilitated extinction recall, whereas 
estradiol receptor antagonists impaired it. 
Estradiol administration into Hippocampus in 
female rats facilitated fear extinction 
[27].Collectively, these data suggest that gonadal 
hormones influence the consolidation of extinction 
memory. 
Our results indicate that rats given β-estradiol, 
immediately after shock presentation (fear 
conditioning), showed decreased percentage of 
freezing time as compared with SPS group that 
received sesame. Comparison of conditioned fear 
responses between tests 1 and 5, in each group, 
showed that there was significant decrease in fear 
in SPS+β estradiol group, but this response 
remained constant in SPS+sesame oil group. In 
other words, multiple injection of β estradiol 
reduced the fear response, the same as what 
happened in shock group; it alleviates the 
enhanced fear induced by SPS. Accordingly, the 
recuperative effect of β estradiol not only abided, 
but also invigorated after five tests. These findings 
support our previous data and indicate that 
prescribing β estradiol immediately after traumatic 
events could prevent memory impairment in 
PTSD patients. 
β-estradiol and cell density 
    At the end of the behavioral tests, the animals 
were perfused and the density of cells in 
hippocampus was measured after removal of the 
brains and processing the tissues. Although we 
didn‟t measure total volume of hippocampus, our 
results indicated that SPS decreases the density of 
cells in right and left hippocampus and that this 
decrease was improved by β-estradiol. The 
number of CA1 and CA3 pyramidal cells in 
SPS+β-estradiol group was significantly more 
than SPS+sesame oil group. SPS+sesame oil 
 




group showed significant decrease in the number 
of cells as compared with Shock+Sesame group. 
There was no difference between the two groups 
regarding the number of cells in DG region of 
hippocampus. Decreased hippocampal volumes in 
PTSD is confirmed by the present findings. 
Estradiol is a neuroprotective factor that decreases 
cell death in a variety of in vitro and in vivo 
paradigms of brain injury [28]. 
Previous reports implicate E2 as a modulator of 
Ca2+ concentration in mitochondrial matrix, and 
ultimately in the cytosol. Given the vital role of 
Ca2+ in regulation of total nerve cells activity, 
especially energy metabolism, neurotransmission 
and directing the cells toward survival or cell 
death, the effects on mitochondrial Ca2+ transport 
could be one of the important modes of E2 
neuromodulatory action independent of the 
genome [28]. 
Apoptosis is tightly regulated by anti apoptotic 
and pro apoptotic effector molecules and may be 
one of the inducing reasons for hippocampus 
decrease in cell density or atrophy in PTSD. 
Mitochondrial pathway participated in SPS-
induced apoptosis, including Bcl-2 family, 
cytochrome C caspase-9 and caspase-3. However, 
more researches are needed in order to achieve a 
better understanding of the molecular mechanism 
underlying SPS induced apoptosis, which may 
provide important information for the treatment of 
PTSD. Probably, β-estradiol affects the cell 
density in hippocampus by its anti-apoptotic 
effect. 
β-estradiol and BDNF 
     BDNF has been postulated to be an important 
signaling molecule in regulating synaptic strength 
and overall circuit activity in the adult. BDNF 
plays a critical role in activity-dependent 
neuroplasticity underlying learning and memory 
in Hippocampus. Previous studies suggest that 
animals with reduced BDNF have diminished 
extinction of fear. Furthermore, diminished BDNF 
in Hippocampus is thought to possibly be related 
to the decreased hippocampal volume found in 
patients with major depressive disorder and 
posttraumatic stress disorder (PTSD).These 
disorders have also been hypothesized to result in 
part from a deficit in extinction of fear [29]. 
There is a growing body of evidence 
demonstrating that stress decreases the expression 
of brain-derived neurotrophic factor (BDNF) in 
limbic structures that control the mood and also 
that antidepressant treatment reverses or blocks 
the effects of stress. Decreased levels of BDNF, as 
well as other neruotrophic factors, could 
contribute to the atrophy of certain limbic 
structures, including Hippocampus and prefrontal. 
Conversely, the neurotrophic actions of 
antidepressants could reverse neuronal atrophy 
and cell loss and thereby contribute to the 
therapeutic actions of these treatments [30].  
In this study, we found out that hippocampal cell 
density was reduced in SPS groups as compared 
with shock group and this reduction was 
recovered by estradiol treatment. Neurotrophins, 
and particularly BDNF, may have a major 
protective role against neuronal damage by 
stimulation of sprouting and synaptic 
reorganization, promoting resilience of brain cells 
to cope with stressful challenges. Because BDNF 
expression in the adult hippocampus is required 
for precursor cell survival, exercise-induced cell 
proliferation, and dendritic development [31], we 
measured BDNF protein levels after the first (day 
9) and fifth (day 13) tests in SPS+sesame oil and 
SPS+β-estradiol groups by ELISA. There was a 
significant difference between the SPS+sesame oil 
and SPS+β-estradiol groups 9 days after SPS 
induction. In this study, we found out that SPS rats 
treated with Estradiol showed an increase in the 
levels of BDNF protein on the first test.  May be 
Estradiol up-regulates the induction of BDNF 
levels in Hippocampus. This difference was not 
found to be statistically significant 13 days after 
SPS, when the animals had not received Estradiol 
for 5 days. 
We found out that BDNF protein level was 
negatively correlated with freezing response in 
SPS rats. This study suggests that the enhanced 
levels of BDNF during fear memory test is, at 
least in part, associated with decrease in fear 
memory in SPS rats which were treated with 
Estradiol. The rats with higher fear response 
possess lower level of BDNF in their 
hippocampus. The higher induction of BDNF 
response to Estradiol in SPS rats may contribute to 
the difference in freezing between the SPS groups 
which received Sesame oil and Estradiol. 
Preclinical studies have demonstrated that 
exposure to footshock or maternal separation 
reduced hippocampal BDNF expression through a 
down-regulation of its mRNA levels. Dell‟Osso et 
al. (2009) recently showed significantly lower 
plasma BDNF levels in PTSD patients as 
compared with matched. In contrast, a recent case 
report demonstrated elevated serum BDNF levels 
in 2 cases [32]. In another report they have shown 
that patients who were recently exposed to trauma 
 




presented higher BDNF levels as compared with 
controls. They suggest that serum levels of brain-
derived neurotrophic factor, in PTSD, are 
increased immediately after trauma. But this 
increase is not persistent and declines after several 
days [33]. Actually, it is also possible that an 
increase in BDNF, immediately after trauma, 
reflects an attempt to compensate for other 
neurobiological alterations that occur in PTSD. 
Further studies are required to elucidate whether 
BDNF is associated with the pathophysiology of 
PTSD. 
Based on the findings of this study, it is 
conceivable that the pathophysiology of PTSD, 
leading to the declined extinction of fear memory, 
may be in part due to impairment of BDNF. 
Moreover, the enhanced BDNF also would 
participate in the facilitation of fear extinction. 
However, it cannot be ruled out that up-regulation 
in BDNF is coincident with the enhanced 
extinction of fear memory. Further studies are 
required to elucidate the involvement of BDNF in 
the enhanced extinction of fear memory and the 
effects of Estradiol on this function. 
It is well established that estrogen is involved in 
the differentiation and plasticity of hippocampal 
neurons. Estrogen receptor is colocalized with 
BDNF in hippocampal pyramidal neurons and 
there is a direct action of estrogen receptor on the 
BDNF gene in pyramidal cells. It is possible that 
estrogen regulates the expression of BDNF 
indirectly through a step involving other 
transcription-regulating factors [34]. BDNF and its 
receptor trkB regulate both short-term synaptic 
functions and long-term potentiation (LTP). 
Estrogen has similarly been shown to enhance 
LTP and may regulate neural processes underlying 
learning and memory. The mechanisms by which 
estrogen modulates LTP are essentially unknown, 
but one possibility could be through interactions 
with the BDNF gene [34]. 
Several findings demonstrate that hormone 
replacement significantly affects relative levels of 
BDNF mRNA and protein within specific regions 
of the brain. These effects may, in turn, contribute 
to the effects of estrogen replacement on 
hippocampal connectivity and cognitive processes 
that have recently been reported. Estrogen 
replacement in young adult, ovariectomized, 
female rats increases BDNF expression in the 
olfactory bulb, hippocampus, cortex, amygdala, 
septum dorsolateral area of the bed nucleus 
terminalis and the lateral habenular nucleus. In 
ovariectomized, aged female rats, estrogen 
treatment increases BDNF, NGF and NT3 in the 
entorhinal cortex(Cavus and Duman, 2003). 
Estrogen also increases BDNF expression in 
Hippocampus of gonadectomized male mice. 
However, in some reports, estrogen has no effect 
on several cortical brain regions, Hippocampus or 
the nucleus/ventral pallidum. High endogenous 
estrogen levels during the estrus cycle are 
associated with decreased BDNF mRNA in 
Hippocampus and prefrontal cortex. Moreover, 
BDNF protein expression in the forebrain region 
is also down-regulated by exogenous estrogen 
replacement [35]. 
Some of these results are similar to ours, 
demonstrating an estrogen-induced increase in 
BDNF levels in hippocampal targets.  
In summary, although there are some limitations, 
the results of these studies are consistent with the 
hypothesis that decreased expression of BDNF 
contributes to memory impairment in PTSD and 
that up regulation of BDNF by β-estradiol plays a 
role in memory treatment. 
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